The QualityStocks Daily Stock List
- HD View 360, Inc. (HDVW)
- REGI U.S., Inc. (RGUS)
- BlackRidge Technology International, Inc. (BRTI)
- Cannabis Sativa, Inc. (CBDS)
- Strata Oil & Gas, Inc. (SOIGF)
- LiCo Energy Metals, Inc. (WCTXF)
- Lion One Metals Limited (LOMLF)
- NRG Metals, Inc. (NRGMF)
- BioCorRx, Inc. (BICX)
- Inception Mining, Inc. (IMII)
- BioHiTech Global, Inc. (BHTG)
- Humanigen, Inc. (HGEN)
HD View 360, Inc. (HDVW)
OTC Markets, MarketWatch, TradingView, and MarketNewsUpdates reported on HD View 360, Inc. (HDVW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A full-service Information Technology (IT) company, HD View 360, Inc. and its subsidiary companies are a complete Business-to-Business (B2B) Information Technology solution. The Company provides hardware installation, security monitoring systems, telephone services, merchant processing, Point-of-Sale (POS) software, and continuing IT support to small and medium-sized businesses (SMBs). HD View 360 is headquartered in Miami, Florida.
The Company has practical experience in almost every aspect of retail operations. One of HD View 360’s wholly-owned subsidiaries is SimpleFone. This subsidiary is an innovative Voice over Internet Protocol (VoIP) provider. At present, SimpleFone is selling its telephone services to numerous nationally-recognized franchise brands. HD View 360 is positioning SimpleFone to become a foremost VoIP carrier.
SimpleFone has secured a data housing center close to its headquarters in Miami, with a redundancy center in Phoenix, Arizona. It also purchased a new VoIP phone switch that can service up to 100,000 phone lines at the same time.
Recently, SimpleFone has been overhauling its infrastructure to prepare for an influx in growth by launching a more consumer-driven website, introducing its Simple Affiliate Partner sales program, implementing new software and POS/CRM integration functionality, and creating a much safer and secure SRTP/TLS compliant encryption platform. By way of these upgrades, and more, SimpleFone’s plan is to further support its increasing list of consumer and investor needs.
HD View 360 and Voice Solutions, Inc. announced last month a new strategic partnership. This partnership will take advantage of access to enterprise-level customers and create mutual avenues of recurring revenue streams for both businesses.
Voice Solutions is one of the top providers of in-store music, on-hold message services, digital signage, sound masking, and other impactful sensory marketing services. Voice Solutions is the first member of HD View 360’s Simple Affiliate Partner Program.
HD View 360 recently announced the launched of development of its proprietary POS Software via its wholly-owned subsidiary, HD View Technologies. The specific design of this POS solution is with the franchise and multi-location retail segment in mind.
The Company’s POS solution will seamlessly integrate its client's businesses, products, customers, and payment systems into one user-friendly platform. The next generation POS software will take advantage of HD View 360's merchant processing service and its years of experience working with franchise brands to provide clients with a complete and specialized retail solution.
Last week, HD View 360 announced that subsidiary HD View Technologies signed its first Letter of Intent (LOI) with Pizzafire. This is to supply its POS technology to all locales across the country. The next generation POS will enable the growing restaurant chain to more efficiently staff, save time on menu updates, as well as keep closer tabs on new locations.
Of note is that 19 Pizzafires are open, 15 more are planned by the end of 2017, and there are numerous POS systems per location. HD View 360’s anticipation is that this contract will be a considerable revenue generator in the months ahead.
HD View 360, Inc. (HDVW), closed Thursday's trading session at $0.02, up 100.00%, on 5,200 volume with 2 trades. The average volume for the last 60 days is 1,135 and the stock's 52-week low/high is $0.01/$5.31.
REGI U.S., Inc. (RGUS)
MarketWatch, Marketwired, and Stockhouse reported on REGI U.S., Inc. (RGUS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
REGI U.S., Inc. via its subsidiary, RadMax Technologies, Inc., engages in the design and development of axial vane-type rotary engines, known as the RadMax rotary technology, used in the design of engines, compressors, and pumps. RadMax Technologies is developing for commercialization multiple improved axial vane type rotary devices utilizing its Patented RadMax™ Rotary Technology. OTCQB-listed, REGI U.S. is based in Spokane, Washington.
The RadMax™ Rotary Technology allows for ground-breaking designs of lightweight and high efficiency engines, compressors, pumps, as well as other devices. One current prototype is The RadMax™ engine. It has only two unique moving parts, the vanes (up to 12) and the rotor, versus the 40 moving parts in a basic four-cylinder piston engine.
The inventive design makes it possible to produce up to 24 continuous power impulses per one rotation, which is vibration-free and very quiet. In addition, the RadMax™ engine has a number of capabilities permitting it to operate on fuels such as gasoline, natural gas, hydrogen, propane, and diesel.
Recently, the Board of Directors of REGI U.S. and its wholly owned subsidiary, RadMax Technologies announced engineering improvements and prototype testing results. Because of the Company’s research, testing, and prototype development, the Board also announced the filing of two new patents and three provisional patents. Furthermore, other designs and RadMax technology enhancements are in the plans for future patent consideration.
This month, the Board of Directors of Regi U.S. and RadMax Technologies announced the appointment of Mr. Paul L. Porter as President of Regi U.S. and RadMax Technologies. The Board of Directors selected Mr. Porter to fill the role of President and Chief Technology Officer (CTO) after having served as its VP Engineering for the last year.
Mr. Porter has a wide-ranging background in Mechanical Engineering. He has built a globally respected aerospace seal technology company. Also, he has continually advanced the RadMax Technology. As President, he will serve as the principal technology voice of the Company. Additionally, he will work alongside Mr. Paul W. Chute, the Chief Executive Officer (CEO), in advancing Regi U.S. and RadMax Technologies.
In essence, the Company’s objective is to license RadMax technology and/or participate in joint ventures (JVs) to manufacture RadMax products for specific applications. Market segments that could benefit from RadMax technology include (but are not limited to) transportation, aerospace, air conditioning and refrigeration, oil and gas production and distribution, power generation, marine, and military markets.
REGI U.S., Inc. (RGUS), closed Thursday's trading session at $0.07, up 6.06%, on 17,530 volume with 3 trades. The average volume for the last 60 days is 14,094 and the stock's 52-week low/high is $0.0515/$0.30.
BlackRidge Technology International, Inc. (BRTI)
Stockhouse, MarketWatch, OTC Markets, Barchart, Stockopedia, AwesomePennyStocks, and Investors Hangout reported on BlackRidge Technology International, Inc. (BRTI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
BlackRidge Technology International, Inc. is a foremost provider of next generation cyber defense solutions. The Company provides solutions that stop cyber-attacks and block unauthenticated access. BlackRidge formed in 2010 to commercialize its military grade and patented network security technology. BlackRidge Technology International is based in Reno, Nevada.
The Company’s products are used in enterprise and government computing environments, the industrial Internet of Things (IoT), as well as other cloud service provider and network systems. BlackRidge’s patented First Packet Authentication™ technology was developed for the military to cloak and protect servers and segment networks. First Packet Authentication™ is the ability to ascertain the identity of the originator of a TCP session on the very first packet of the TCP session. This is before any response is made to the requestor.
BlackRidge Transport Access Control (TAC) authenticates user and device identity. In addition, it enforces security policy on the first packet of network sessions. TAC, utilizing the Company’s patented First Packet Authentication™, provides a new level of cyber defense for network and cloud resources. TAC operates pre-session, in real-time, before other security defenses engage.
This new level of real-time protection blocks or redirects unidentified and unauthorized traffic to halt attacks and unauthorized access. Moreover, it isolates systems and segments networks and provides identity attribution.
Earlier this month, BlackRidge Technology International announced its designation as a Distinguished Vendor in the 2018 TAG Cyber Security Annual. Additionally, the report named BlackRidge CTO (Chief Technology Officer), Mr. John Hayes, as a Cyber Luminary and interviewed Mr. Hayes on Micro-Segmenting Data Centers and Networks Using Strong Separation and Abstraction.
The Distinguished Vendor recognition is an exclusive acknowledgement of companies, which demonstrate unique innovation in addressing modern cyber security threats. Each Distinguished Vendor was selected by Dr. Edward Amoroso, CEO (Chief Executive Officer) of TAG Cyber, to assist with this year's report.
Yesterday, BlackRidge Technology International announced it is pleased to sponsor and deliver a keynote address at NYIT's Eighth Annual Cybersecurity Conference, taking place at the New York Institute of Technology Auditorium on Broadway in New York, New York on Thursday, September 28, 2017. Presented by the NYIT School of Engineering and Computing Sciences, the Eighth Annual Cybersecurity Conference brings together cyber experts from academia, business, and government.
BlackRidge Technology International, Inc. (BRTI), closed Thursday's trading session at $0.34915, down 8.12%, on 63,900 volume with 10 trades. The average volume for the last 60 days is 14,438 and the stock's 52-week low/high is $0.10/$2.00.
Cannabis Sativa, Inc. (CBDS)
Cannabis Financial Network News, Greenbackers, TheMicrocapNews, TopStockAnalysts, Flagler Financial Group, Promotion Stock Secrets, Jason Bond, Marketbeat.com, TopPennyStockMovers, Stockgoodies, Top Pros’ Top Picks, Insider Financial, Darwin Investing Network, Wall Street Mover, Stock Beast, smartOTC, and Real Pennies reported earlier on Cannabis Sativa, Inc. (CBDS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Cannabis Sativa, Inc. involves in branding and licensing by way of its 'hi' intellectual properties. The Company engages, through its subsidiaries, Wild Earth Naturals and "hi" Brands International, Inc., in the research, development, and licensing of specialized natural products. These include formulas, edibles, topicals, recipes, as well as delivery systems. Cannabis Sativa has been active in pursuing Intellectual Property (IP) and has successfully acquired a growing portfolio of IP. Based in Mesquite, Nevada, Cannabis Sativa’s shares trade on the OTC Markets’ OTCQB.
Cannabis Sativa brands, licenses, innovates, and markets first-rate plant-derived topical creams, transdermals, balms, sublinguals, lubricants, and edibles for medical and recreational marijuana consumers, and legal nutraceuticals and branded merchandise for consumers in general. The Company’s objective is to license the "hi" brand to distributors and producers of quality products and to other ancillary participants in the retail cannabis industry.
Cannabis Sativa has acquired a majority ownership interest in iBudtender, Inc., a Colorado corporation. In addition, it entered into an agreement to acquire a 49 percent ownership interest in a nine-acre property in Los Angeles County, California. The ownership group’s plan is to lease the property to an industrial hemp farm operator. The operator will conduct farming activities under the Industrial Hemp provisions of California's Adult Use Marijuana Act (Prop 64).
Cannabis Sativa has its Wild Earth Naturals offerings. The Company offers the Wild Earth Naturals line of CBD Water and cosmetic products designed to use organic and natural ingredients. These include CBD and hemp seed oil. Cannabis Sativa’s wholly-owned subsidiary, Hi Brands International, entered into an agreement with Centuria Natural Foods, Inc. to market their proprietary CBD Rich Hemp Oil products. Their CBD capsules are marketed under the name, "hi CBD."
Cannabis Sativa has entered into a license agreement for the manufacture, marketing, and sale of its White Rabbit products in California. The Company closed its acquisition of the White Rabbit brand of cannabis sprays and cannabis mints. The acquisition includes the exclusive and proprietary product formulations, product mixes, manufacturing methods, and branding. The White Rabbit product line now consists of fast-acting low dose cannabis oral sprays and low dose cannabis mints. Cannabis Sativa has developed a "hi" branded infused honey product (hi honey) made from rich African honey and infused with CBD or THC.
Cannabis Sativa has acquired a controlling interest in PrestoCorp (a.k.a. PrestoDoctor). This is an online telemedicine platform. It provides access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation utilizing secure video conferencing technology. Appointments via PrestoDoctor's website are usually completed in 10-15 minutes. They can be scheduled and completed in the same day.
PrestoDoctor has greater than 4,000 5-star reviews. It is the first medical marijuana company to be accepted into the American Telemedicine Association. PrestoDoctor is HIPAA and HITECH compliant.
Cannabis Sativa announced in September that it granted an exclusive license to the Sowilde Management Group, Inc. This is to allow Sowilde to produce products under Cannabis Sativa’s "hi" and "White Rabbit" brands. The initial products offered to the market by Sowilde are the White Rabbit line of cannabis sprays and cannabis mints and hi Infused Wild Honey.
Cannabis Sativa, Inc. (CBDS), closed Thursday's trading session at $3.73, up 5.37%, on 327,058 volume with 893 trades. The average volume for the last 60 days is 109,907 and the stock's 52-week low/high is $1.915/$9.74.
Strata Oil & Gas, Inc. (SOIGF)
AllPennyStocks and Investing Daily reported earlier on Strata Oil & Gas, Inc. (SOIGF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Strata Oil & Gas, Inc. is an enterprise leading the field in the exploration and development of bitumen from carbonates in the Province of Alberta. The Company concentrates on the exploration and development of heavy oil and bitumen. It has an interest in oil sands leases in the Peace River oil sands region of northern Alberta. Incorporated in 1998, Strata Oil & Gas is headquartered in Peace River, Alberta.
Strata Oil & Gas’ land base comprises approximately 60,672 hectares (over 149,000 acres) in the Peace River area. The estimation is that this region contains in excess of 188 billion barrels of oil. The Peace River oil sands area is one of the most productive oil-producing areas in Alberta.
Strata’s Cadotte Central project is just north of Shell Canada's Carmon Creek project. It is adjoining Husky's property holdings in Peace River. Strata’s Cadotte West project is just north of Shell Canada's Carmon Creek project. It is adjacent to Koch Industries and Penn West property holdings in Peace River.
In 2016, Strata Oil & Gas entered into an agreement to acquire the rights to greater than 20,000 acres of oil sands leases in the Peace River oil sands area. This increases the size of its Alberta oil sands holdings by a factor of around 50 percent. The rights extend from the Peace River formation to the base of the Pekisko formation. These lands are next to the Company’s Cadotte Project. They are within the same carbonate trend.
Strata Oil & Gas entered into an agreement to acquire the rights to 115 sections (73,600 acres) of oil sands leases in the Peace River oil sands region. This increases the size of its Peace River Alberta oil sands holdings to greater than 230 sections. The lands are neighboring Baytex Energy Corp.'s Reno project lease block in the southern portion of the Peace River oil sands region. This is an area with extensive primary production. The new lease area is complementary to the Company’s existing Cadotte Project.
Strata Oil & Gas announced this past February that it entered into a Letter of Intent (LOI) with Petrosteam LLC to obtain an exclusive license to deploy patented and field tested proprietary technologies utilizing steam generation applied to bitumen and heavy oil recovery (the Petrosteam Technology) in Alberta and Saskatchewan.
With this exclusive license, it has the exclusive right to use the Petrosteam Technology to produce within Alberta and Saskatchewan from its own properties and from those of others.
The Petrosteam Technology has been field tested. Petrosteam is the exclusive owner of the patented Petrosteam Technology on an international basis.
Strata Oil & Gas believes that carbonate-hosted bitumen is one of the next major frontiers in the oil industry in the Province of Alberta. The Company has positioned itself to take advantage of this.
Strata Oil & Gas, Inc. (SOIGF), closed Thursday's trading session at $0.045, up 50.00%, on 1,940 volume with 4 trades. The average volume for the last 60 days is 2,720 and the stock's 52-week low/high is $0.012/$0.249.
LiCo Energy Metals, Inc. (WCTXF)
Stockhouse, InvestorsHub, Barchart, SmallCapVoice, Streetwise Reports, OTC Markets, MarketWatch, Metals News, and StockoftheWeek reported on LiCo Energy Metals, Inc. (WCTXF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
LiCo Energy Metals, Inc. conducts exploration for metals used in the production of lithium-ion batteries. The Company has four ongoing projects in mining-friendly jurisdictions within the United States, Canada, and Chile. It has a growing portfolio of promising projects, all with goals of developing battery-grade lithium or cobalt. LiCo Energy Metals is based in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.
LiCo’s projects include the Glencore Bucke Property, the Teledyne Cobalt Project, the Purickuta Exploitation Project, the Dixie Valley Lithium Project, and the Black Rock Desert Lithium Project. The Glencore property consists of 16.2 hectares. It sits along the west boundary of the Company’s Teledyne Cobalt Project.
The Purickuta Project consists of 160 hectares. It is one of a few "exploitation concessions" granted within the Salar de Atacama, home to about 37 percent of the world’s Lithium production.
The Teledyne Cobalt Project consists of 5 mining claims and 6 staked crown claims in the Buck and Lorrain Townships, in the district of Temiskaming, Ontario. This project covers 115.5 hectares of mining and surface rights, with an additional 439.1 hectares of staked crown claims.
LiCo Energy Metals earlier entered into an option to acquire 100 percent, Net 3 Percent Smelter royalty to acquire 348 claims in the Dixie Valley Exploration Project in Churchill County, Nevada. Moreover, it entered into an option agreement where it may earn an undivided 70 percent interest subject to a 3 percent Net Smelter Return Royalty in the existing Black Rock Desert Lithium Project. This Project consists of 199 placer claims (3,980 acres/1,610 hectares) in southwest Black Rock Desert, Washoe County, Nevada.
This past April, LiCo Energy Metals announced its proposed Exploration Programs for its Teledyne & Glencore Bucke Cobalt Properties in Ontario, located in Bucke & Lorraine Townships, 6 km east-northeast of Cobalt, Ontario. Regarding the Glencore Bucke Cobalt Property, a surface exploration work program including geological mapping and prospecting is recommended to further evaluate the geological potential of the Property.
Regarding the Teledyne Cobalt Property, a surface exploration work program including geological mapping, prospecting, and mechanized stripping is recommended for the Property. Planned work will amass and evaluate historical showings and past exploration work to generate exploration targets on the unpatented and patented mining claims.
LiCo Energy Metals, Inc. (WCTXF), closed Thursday's trading session at $0.028, down 5.08%, on 74,640 volume with 15 trades. The average volume for the last 60 days is 157,457 and the stock's 52-week low/high is $0.023/$0.895.
Lion One Metals Limited (LOMLF)
TopStocks, Barchart, Stockhouse, Stock Twits, Investors Hub, OTC Markets, Junior Mining Network, MarketWatch, Morningstar, Nasdaq, Canadian Mining Report, Investor Ideas, StreetWise Reports, TradingView, Mining Atlas, Mining, Stock World, and Investing reported on Lion One Metals Limited (LOMLF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Lion One Metals Limited focuses on advancing to production at its 100 percent owned and fully permitted high grade underground Tuvatu Gold Project. Tuvatu is situated on the island of Viti Levu in the Republic of Fiji. A mineral exploration and development company Lion One Metals is based in Vancouver, British Columbia. The Company lsists on the OTC Markets’ OTCQX. Lion One Metals also offices in Fremantle, Australia and in Waimalika, Nadi, Republic of Fiji.
Lion One Metals is focused on cost effective and environmentally responsible construction, development, and advancement of Tuvatu towards production. This is tied with exploration of its district-scale license areas covering the highly prospective and underexplored Navilawa volcano. The Company is advancing Tuvatu as a near-term production opportunity with exploration upside in the southwest Pacific Ring of Fire.
Lion One Metals has modeled Tuvatu for exploration after regional giants in the low sulphidation family of high grade epithermal gold deposits. This includes Porgera and Lihir in Papua New Guinea, and Vatukoula in Fiji, which boast production of greater than 35 million ounces of gold in similar alkaline volcanic settings.
The Company is centered on building production of 100,000 oz. per year over 10 years. Lion One Metals holds a 200 km² exploration license package encompassing the entire Navilawa volcano, with the Tuvatu mining lease at its center. Tuvatu is the largest undeveloped gold project in Fiji. Furthermore, it is one of the highest-grade gold projects anywhere in the world.
Lion One Metals announced in February 2018 that an expansive surface exploration program began at its high grade Tuvatu Gold Project. The 2018 surface program is being carried out within the permitted area of the Tuvatu Mining Lease (SML 62). It comprises Phase One, which includes excavator benching with detailed mapping and sampling, followed by a Phase Two drilling program.
Recently, Lion One Metals announced that it entered into an indicative term sheet with Sinosteel Equipment & Engineering Co., Ltd. of China and Baiyin International Investment Ltd. This term sheet incorporates an EPC and gold doré off-take financing facility totaling US$40 million for mine development and construction of the processing plant for Lion One Metals’ Tuvatu Gold Project.
Following the discovery of a new mineralized lode from benching, which returned a (non-representative) select sample of 502 g/t gold over 0.70 m, Lion One's Fiji exploration team has mapped over 20 previously undefined mineralized structures at the Jomaki-Ura Creek prospect areas. The team has also identified potential geological extensions on the main mineralized zones inside the Tuvatu Mining Lease (SML 62).
Lion One Metals Limited (LOMLF), closed Thursday's trading session at $0.40, even for the day. The average volume for the last 60 days is 5,536 and the stock's 52-week low/high is $0.3478/$0.615.
NRG Metals, Inc. (NRGMF)
Stockhouse, The Street, MarketWatch, Barchart, and 4-Traders reported earlier on NRG Metals, Inc. (NRGMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
NRG Metals, Inc. searches for brine-based lithium targets in Argentina, Bolivia, and Chile. It has positioned itself for fast growth in the brines of South America. NRG Metals is operating in miner-friendly jurisdictions with first-class infrastructure, targeting battery-grade lithium and other forms of metal. NRG Metals is headquartered in Vancouver, British Columbia and the Company lists on the OTC Markets’ OTCQB.
NRG Metals’ aim is to quickly enter the lithium market through developing technically uncomplicated, limited environmental footprint projects in Argentina. The Hombre Muerto North Project in Argentina is in an area of lithium production and development. The Salar Escondido Project in Argentina is a drill ready, fully permitted, 29,000-hectare claim block. It represents an exploration opportunity to make a significant new lithium discovery.
NRG Metals’ focus is on identifying and establishing a project with the intent of producing an industrial grade lithium product. The Hombre Muerto North Project is a 3,297-hectare claim package comprising six concessions in Salta Province. Twenty surface samples collected in 2016-2017 range from 48 to 1,064 mg/L Li, averaging 587 mg/L Li, with seven samples more than 800 mg/Li. The property package comprises the Alba Sabrina, Tramo, Natalia Maria, Gaston Enrique, Viamonte, and Norma Edit concessions.
The Salar Escondido Project is in Catamarca Province, 40km south of Antofagasta de la Sierra. The Project area is strategically situated within the Lithium Triangle, in close proximity to one of the largest known lithium deposits in Argentina, and within the Puna Region. The region is an elevated plateau, which lies on the eastern side of the Andes Mountains. The area contains a number of highly mineralized salars. This includes the lithium producing salars – the aforementioned Hombre Muerto.
NRG Metals controls a dominant portion of the basin with 29,192 hectares under option. Surface sampling in fresh water zones returned anomalous Li values up to 50ppm and high carbonate values. Preliminary interpretation indicates four distinct zones.
Last week, NRG Metals reported additional assays from the second diamond drill hole at the Hombre Muerto North lithium project. The samples were taken from depths ranging from 91.0 to 230.5 m below surface. These assays range from 779 to 507 mg/L lithium with low Mg to Li ratios ranging from 2.3 to 3.0. The average for the entire hole is 638 mg/L Lithium with a Mg to Li ratio of 2.65 to 1.0.
Mr. Jose de Castro, Chief Operating Officer of NRG Metals, said, "We are extremely enthusiastic about the diamond drilling results, as well as the results from the pumping well. These results demonstrate the presence of high-grade lithium bearing brine across the breadth of our Tramo property. We look forward to completing the second pumping well and to fast tracking the project to production."
NRG Metals, Inc. (NRGMF), closed Thursday's trading session at $0.1714, down 6.85%, on 203,796 volume with 55 trades. The average volume for the last 60 days is 303,152 and the stock's 52-week low/high is $0.0737/$0.7939.
BioCorRx, Inc. (BICX)
OTPicks, Damn Good Penny Picks, Penny Stock Newsletter, Equity Observer, SmallCapVoice, Value Penny Stocks, MassiveStockProfits, BUYINS.NET, PREPUMP STOCKS, Penny Picks, and PennyStocks24 reported previously on BioCorRx, Inc. (BICX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
BioCorRx, Inc. is a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions. The Company provides an innovative approach to the treatment of substance abuse addiction and has its BioCorRx® Recovery Program. The BioCorRx® Recovery Program is a non-addictive, medication-assisted treatment (MAT) program. BioCorRx’s emphasis is on improving the quality of life for recovering addicts. Listed on the OTCQB, the Company has its headquarters in Anaheim, California.
The BioCorRx® Recovery Program consists of two main components. The first component consists of an outpatient implant procedure performed by a licensed physician. The implant delivers the non-addictive medicine, naltrexone, an opioid antagonist that can considerably reduce physical cravings for alcohol and opioids. The second component is a one-on-one proprietary counseling program. It is mainly tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatments.
BioCorRx has also expanded the support structure to include 12 months of a peer-support system using trained recovery specialists. In addition, the Company is developing a patent pending injectable form of naltrexone.
BioCorRx Pharmaceuticals is the Company’s research and development (R&D) subsidiary. At present, BioCorRx Pharmaceuticals is developing a new injectable naltrexone technology (BICX101) through a partnership with TheraKine Ltd. BICX101 is a sustained release, injectable naltrexone for the treatment of opioid abuse and alcoholism. BioCorRx’s plan is to seek Food and Drug Administration (FDA) approval for BICX101 and/or its naltrexone implant product(s).
This past May, BioCorRx® announced that it submitted a grant application to the National Institutes of Health (NIH) to fund the development and study plans for BICX102, its sustained release naltrexone implant for the treatment of opioid and alcohol use disorders. Moreover, in June, the Company announced it completed a capital raise of $1.1 million. This capital enables BioCorRx to continue to work towards FDA approval of BICX102.
BioCorRx, Inc. (BICX), closed Thursday's trading session at $0.11, down 0.99%, on 144,816 volume with 22 trades. The average volume for the last 60 days is 179,466 and the stock's 52-week low/high is $0.0426/$0.282.
Inception Mining, Inc. (IMII)
Stock Commander, Streetwise Reports, PennyStocks24, Information Solutions Group, and Charms Investments reported previously on Inception Mining, Inc. (IMII), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Inception Mining, Inc. engages in the acquisition, exploration, and development of precious metal properties - principally gold-related. The Company’s chief target properties are those that have been the subject of historical exploration having substantial supporting data. Inception Mining is based in Murray, Utah.
In August 2014, Inception Mining announced that it entered into an Ore Processing Agreement with New Jersey Mill Joint Venture (NJ Mill), a floatation mill that can process 360 metric tonnes daily. The mill is in Kellogg, Idaho. NJ Mill will process Inception Mining's bulk samples.
Inception Mining holds interest in the U.P. and Burlington Gold Mine. This includes two Federal patented mining claims in the County of Lemhi, Northwest of Salmon, Idaho. The U.P. and Burlington Mine is within the Salmon National Forest. The mine is considered to be within the Eureka Mining District.
Clavo Rico Ltd. is the Company’s wholly-owned subsidiary. It assumed management control of Clavo Rico’s operation, the Cerros Del Sur operation in Honduras, Central America. Clavo Rico has primary operations in Honduras. Clavo Rico operates two subsidiaries and holds other mining concessions. Inception Mining’s main mine is positioned on the 200 hectare Clavo Rico Concession, in southern Honduras.
Inception Mining announced in October of 2017 the completion of the expansion project at its Clavo Rico Project. The processing capacity of excavation, hauling, and crushing facilities was increased to 500 -750 tpd. In addition, stacking capacity of the leach pad was increased from 400,000 tonnes to more than 750,000 tonnes.
Inception Mining also announced in October 2017 that it entered into a Joint Venture (JV) Agreement with Corpus Mining and Exploration Ltd., a company domiciled in the Turks and Caicos. The JV will result in the establishment of a new company, Corpus Gold LLC. With this JV Agreement, Inception Mining will direct and supervise all exploration, drilling, and evaluation initiatives on the Concession.
Pertaining to the above-mentioned Cerros del Sur operation, the Company continues to make improvements in operations and recovery, along with increasing its ore resources. Mine management has secured more mineable properties on its concession. A number of adjacent landowners have placed the surface rights of their lands under contract with the mine.
Inception Mining, Inc. (IMII) closed Thursday’s trading session at
Inception Mining, Inc. (IMII), closed Thursday's trading session at $0.1891, even for the day, on 1 volume with 1 trade. The average volume for the last 60 days is 8,617 and the stock's 52-week low/high is $0.053/$0.35.
BioHiTech Global, Inc. (BHTG)
Zacks, Stockaholics, Stockhouse, MarketWatch, OTC Markets, Market Exclusive, Real Investment Advice, and TradingView reported on BioHiTech Global, Inc. (BHTG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
BioHiTech Global, Inc. is a green technology business that provides unique data-driven solutions for food waste disposal. The Company develops and deploys innovative and disruptive waste management technologies. BioHiTech Global is a leader in zero waste solutions for businesses and municipalities of all sizes. The Company has its corporate office in Chestnut Ridge, New York. BioHiTech Global lists on the NasdaqCM.
The Company provides waste management solutions to a global customer base covering a complete set of technology-based disposal options, which can have a significant effect on waste generation. This is while providing a true zero landfill environment.
BioHiTech Global has launched its BioHiTech Alto™. This is a next generation interactive industrial communication technology. BioHiTech Alto™ enables users to communicate intelligently with industrial equipment in real-time. BioHiTech Alto is a vital new element of the Company’s total food waste solution that uses data and analytics to help drive smarter business decisions. The Company also launched BioHiTech Cirrus. This is a mobile application for consummate insight into the waste stream.
In 2016, BioHiTech Global expanded its waste stream product offering with the launch of Entsorga North America. The Entsorga North America undertaking expands its product offering towards providing disruptive, clean technology solutions that advance the worldwide movement towards sustainability and zero waste initiatives.
At the end of May, BioHiTech Global announced that it received a patent from the U.S. Patent and Trademark Office (USPTO) for a network connected weight tracking system for a waste disposal machine. The new U.S. Patent, No. 9,977,414 (414 Patent), relates to a food waste weight tracking system and method using a waste disposal machine with data network connectivity to transmit weight tracking system information over a computer network, or cloud, for storage, tracking aggregation and sharing by a centralized computer system.
This month, BioHiTech Global announced that it entered into a Letter of Intent (LOI) with Entsorga USA to increase its investment in the nation's first resource recovery facility (Martinsburg Facility) employing a proprietary high efficiency biological treatment (HEBioT) technology for the disposal and recycling of mixed municipal solid waste (MSW). The LOI contemplates BioHiTech Global acquiring up to an additional 30 percent stake in the Martinsburg Facility from Entsorga USA in exchange for shares of BioHiTech common stock to be determined in a definitive agreement. The expectation is that the Martinsburg Facility will produce greater than $7 million in revenue in 2019 when it commences its first year of full operations.
BioHiTech Global, Inc. (BHTG), closed Thursday's trading session at $3.45, up 1.47%, on 16,079 volume with 36 trades. The average volume for the last 60 days is 18,922 and the stock's 52-week low/high is $2.68/$7.65.
Humanigen, Inc. (HGEN)
AmigoBulls, TradingView, OTC Markets, Investopedia, InvestorsHub, Barchart, Investors Hangout, and Financial Times reported on Humanigen, Inc. (HGEN), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Humanigen, Inc. focuses on advancing medicines for patients with neglected and rare diseases via innovative, accelerated business models. Lead compounds in its portfolio include the proprietary monoclonal antibodies, lenzilumab and ifabotuzumab. Derived from its Humaneered® platform, lenzilumab and ifabotuzumab are lead compounds in the portfolio of monoclonal antibodies with first-in-class mechanisms. OTCQB-listed, Humanigen is headquartered in Brisbane, California.
The Company pursues unique science to develop its proprietary monoclonal antibodies for immunotherapy and oncology treatments. Lenzilumab has potential for treatment of different rare diseases. These include hematologic cancers such as chronic myelomonocytic leukemia (CMML), and juvenile myelomonocytic leukemia (JMML). Lenzilumab is a Humaneered® recombinant monoclonal antibody. It neutralizes soluble granulocyte-macrophage colony-stimulating factor (GM-CSF), which is a critical cytokine that drives the growth of certain hematologic malignancies.
The other key asset in Humanigen’s monoclonal antibody portfolio, ifabotuzumab, has been dosed in the first patient in an investigator-sponsored Phase 0/1 radio-labeled imaging trial in glioblastoma multiforme (GBM). Ifabotuzumab is a first-in-class, monoclonal antibody. It targets the EphA3 receptor tyrosine kinase created utilizing Humanigen’s proprietary Humaneered® technology.
Lupagen announced this past May the intent to explore the development of a bedside, point-of-care delivered CAR-T therapy with Humanigen. It is developing first-in-class cell and gene therapy delivery technologies for CAR-T, gene editing and immunotherapy products.
Lupagen and Humanigen are planning work to investigate the potential of a bedside CAR-T therapy created from Humanigen's Ifabotuzumab. Lupagen, Inc. is a privately held early stage medical device company.
Last week, Humanigen announced positive topline results from a preclinical study demonstrating that use of its proprietary anti-GM-CSF antibody, lenzilumab, along with CD19 targeted chimeric antigen receptor T-cell therapy (CART19) lessens neurotoxicity (NT) and cytokine release syndrome (CRS) and enhances CART19 proliferation and effector functions. A complete data set from this study has been submitted for presentation to the 2018 Annual Meeting of the American Society of Hematology, which will take place this December.
Humanigen, Inc. (HGEN), closed Thursday's trading session at $0.66625, down 4.82%, on 733 volume with 3 trades. The average volume for the last 60 days is 5,262 and the stock's 52-week low/high is $0.125/$1.00.
The QualityStocks Company Corner
- PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)
- FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)
- Green Hygienics Holdings Inc. (OTC: GRYN)
- Pressure BioSciences Inc. (OTCQB: PBIO)
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)
- Marijuana Company of America Inc. (OTC: MCOA)
- The Flowr Corporation
- Sharing Services, Inc. (OTC: SHRV)
- Youngevity International, Inc. (NASDAQ: YGYI)
- NUGL Inc. (OTC: NUGL)
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: VVCIF)
- Accelerated Technologies Holding Corp. (OTC: ATHC)
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) recently published an investor update detailing its corporate activities (http://nnw.fm/cV3wS), particularly as they relate to its efforts to improve public health through a novel delivery method for cannabis-related products. The report notes PreveCeutical’s successes, underscored by its completion of a $6.5 million financing to inject new capital into its research efforts, as well as general capital purposes.
PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.
PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word “PreveCeutical” – a combination of the words “preventive” and “pharmaceutical” – was a precursor to the company’s formation and incorporation in October 2015.
The company’s first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical’s research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.
PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.
PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical’s gene-silencing technology would effectively “turn off” the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.
Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.
PreveCeutical Medical’s science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland’s (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.
PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.’s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company’s core.
PreveCeutical Medical Inc. (PRVCF), closed the day's trading session at $0.029925, up 10.83%, on 302,830 volume with 29 trades. The average volume for the last 60 days is 646,625 and the stock's 52-week low/high is $0.002/$0.20.
- Update Highlights PreveCeutical Medical’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Efforts to Establish Nature-Based Health and Wellness Products
- PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Acquires Worldwide License for Herbal Sleep Aids
- CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Highlights Recent Milestones in Shareholder Update
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) a royalty company for the U.S. licensed medical cannabis industry is pleased to announce the appointment of Mr. Robert Kamm to its Board of Directors. Mr. Kamm has over 25 years of experience operating and advising businesses from large Fortune 500 corporations to venture capital backed companies and has served on Boards of Directors of both public and private companies during this time period.
FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.
Medical Cannabis Market
According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.
Royalty Model & Portfolio
FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.
FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.
CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.
The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.
Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.
FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.
The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.
FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.221, up 14.86%, on 33,385 volume with 29 trades. The average volume for the last 60 days is 46,389 and the stock's 52-week low/high is $0.10/$0.8736.
- FinCanna Capital Appoints Robert Kamm to its Board of Directors
- CannabisNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Advances $1M Capital Tranche to Refined Resin Technologies
- FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Funds Cannabis Companies with Innovative Royalty Financing Model
Green Hygienics Holdings Inc. (OTC: GRYN)
Green Hygienics Holdings Inc. (OTC:GRYN) today announces the appointment of two experienced professionals to its management team. Mr. Matthew Dole has accepted the role of Senior Vice President of Business Development and Director, while Mr. Jeff Palumbo joins the company as Chief Technology Officer (CTO).
Green Hygienics Holdings Inc. (OTC: GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.
The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.
Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.
Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.
Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.
The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.
Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.
Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.3352, up 4.75%, on 21,033 volume with 10 trades. The average volume for the last 60 days is 68,615 and the stock's 52-week low/high is $0.01/$0.4579.
- Green Hygienics Holdings Inc. Appoints New Management to Lead Key Business Strategies
- Coverage Initiated for Green Hygienics Holdings Inc. (GRYN) via NetworkNewsWire
- Green Hygienics Holdings Inc. to Appoint New CEO
Pressure BioSciences Inc. (OTCQB: PBIO)
Pressure BioSciences (OTCQB: PBIO) this morning announced the award of a key new U.S. patent, entitled ''Flow-through High Hydrostatic Pressure Microfluidic Sample Preparation Device and Related Methods Therefor.'' To view the full press release, visit: http://nnw.fm/s0nLK.
Pressure BioSciences Inc. (OTCQB: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.
The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.
Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”
Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.
The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.
Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.
This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.
The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.
Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.55, up 3.20%, on 866 volume with 6 trades. The average volume for the last 60 days is 1,679 and the stock's 52-week low/high is $0.70/$5.00.
- NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Issued Key U.S. Patent for High-Pressure Flow-Through Microfluidic Sample Preparation Device
- NetworkNewsBreaks – Zacks Research Report Forecasts Pressure BioSciences Inc. (PBIO) to See Major Annual Growth Over the Next Five Years
- NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Collaborating with Ohio State in Disruptive Technology to Preserve Beverages and Liquid Foods
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.
The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.
In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.
Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $2.03, up 1.50%, on 483,555 volume with 669 trades. The average volume for the last 60 days is 217,406 and the stock's 52-week low/high is $0.322/$2.54.
- Lexaria Bioscience Announces Positive Blood-Brain-Barrier Results
- NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Human Clinical Study Confirms Significant Delivery, Bioavailability Results
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Drug Delivery Platform Takes Dosage from Zero to 203 in 15 Minutes
Marijuana Company of America Inc. (OTC: MCOA)
MARIJUANA COMPANY OF AMERICA INC. (OTC: MCOA), an innovative hemp and cannabis corporation, and its joint venture partner Global Hemp Group Inc. (CSE: GHG) (OTC:GBHPF) (FRANKFURT: GHG) (the “Partners”) are pleased to provide an update on their CBD hemp farming joint venture in New Brunswick, Canada (the “Project”).
Marijuana Company of America Inc. (OTC: MCOA) (the “Company”) are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA’s CEO, founded the first marijuana company ever to trade on a U.S. stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.
The CBD market is growing exponentially and consequently the founders of MCOA have constructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can be used to produce products that are carbon neutral or even carbon negative. It is one of the longest, strongest natural fibers on earth, used as a building material that is free of mold, pesticide-resistant, and fire proof. Hemp has also been described as a “super food,” which provides additional business opportunities. No part of the plant is left unused and the Company’s overall strategy is to take advantage of every profit center from farm to the multiple valuable finished products.
The cannabis and hemp industries are experiencing unprecedented growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015’s $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.
The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal cannabis and industrial hemp sectors. The Company’s business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.
Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA’s strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product “hempSMART Brain,” is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience.
Marijuana Company of America Inc. (MCOA), closed the day's trading session at $0.0353, up 2.62%, on 17,102,937 volume with 872 trades. The average volume for the last 60 days is 7,835,424 and the stock's 52-week low/high is $0.022/$0.0728.
- Marijuana Company of America Provides Update on CBD Hemp Joint Venture Farming Project in New Brunswick Canada
- Hemp & Cannabidiol (CBD) Benefits Pushing Consumer Demand to New Highs in Projected Billion Dollar Industry
- Marijuana Company of America Provides Update on Its Investment in Moneytrac Technology
The Flowr Corporation
The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation.
The Flowr Corp. Chairman and Chief Strategist Steve Klein was recently interviewed on The Brave New Weed Podcast hosted by Joe Dolce. The Flowr Corp. is a Canadian licensed producer that focuses primarily on premium flower production. Among other highlights, Klein discussed the company’s partnership with Scotts Miracle-Gro Company’s (NYSE: SMG) subsidiary, Hawthorne Gardening Co. “When we got our license in Canada we signed a deal with them to design and build a 50,000 sq. ft. R&D facility,” Klein stated in the interview. “We should be breaking ground by September right next door to our flagship facility in the Kelowna campus.” To listen to the full podcast, visit http://ibn.fm/PKtcl.
The Flowr Corporation, a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.
Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.
Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.
Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.
In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.
Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.
Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:
- FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
- Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
- Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.
Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.
Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.
- QualityStocksNewsBreaks – The Flowr Corp. Chairman and Chief Strategist Discusses Company Activities, Outlook in Interview on The Brave New Weed Podcast
- The Flowr Corporation is “One to Watch”
- QualityStocksNewsBreaks – The Flowr Corp. Partners with Scotts Miracle-Gro Company (NYSE: SMG) Subsidiary to Conduct Cannabis Testing
Sharing Services, Inc. (OTC: SHRV)
Texas-based Sharing Services, Inc. (OTC: SHRV) focuses on direct selling. The company owns, operates or controls an interest in an array of companies specializing in the direct selling industry. Sharing Services’ mission is to transform the direct selling industry model by creating a diversified holdings company that maintains an ownership interest in numerous direct selling operations. Its mission relies heavily on its implemented ‘Blue Ocean Strategy’.
Sharing Services, Inc. (OTC: SHRV), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRV has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.
Sharing Services Inc. subsidiaries include:
- A growing international network of home-based entrepreneurs, called “Elepreneurs”
- Growing selection of health and wellness products dedicated to elevating the well-being of all people
- Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
- Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
- Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
- Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness
Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.
“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”
The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.
Nearly 1,000 people attended Sharing Services, Inc.’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.
“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”
Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.
The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services, Inc., and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.
John “JT” Thatchwas appointed president and chief executive officer of Sharing Services, Inc., at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.
Sharing Services, Inc. (SHRV), closed the day's trading session at $0.30, even for the day, on 17,360 volume with 5 trades. The average volume for the last 60 days is 18,712 and the stock's 52-week low/high is $0.125/$0.92.
- Sharing Services, Inc. (SHRV) – Specialists in the Direct Selling Industry
- Sharing Services, Inc. Reports Another Record-Breaking Month
- Sharing Services, Inc. (SHRV) Raises Bar for Entrepreneurial Excellence in Increasingly Global Direct Selling Market
Youngevity International, Inc. (NASDAQ: YGYI)
YGYI, Inc. (YGYI), a leading omni-direct lifestyle company, introduced their new Hemp FX™ product line at their 2018 Convention in San Diego, Calif. These products are comprised of three new proprietary blends of hemp-derived cannabinoid products (Soothe™, Relax™, and Uplift™). A limited quantity of the three new formulas were available for Pre- Sale purchase to attendees at Youngevity's Convention and quickly sold-out at the event. Youngevity's Hemp FX™ products will be available for purchase to the public soon with the official launch date to take place by October 2018. Also today, with the release of its second quarter 2018 results, Youngevity International offers a glimpse into coffee’s influence on our social and commercial milieus. This simple beverage, often overlooked because of its ubiquitous use, has been credited with nothing less than catalyzing the industrial revolution (http://nnw.fm/pE5hT).
Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.
Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.
Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.
Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.
Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:
- Health and Nutrition
- Home and Family
- Food and Beverage
- Spa and Beauty
- Essential Oils
- Photo and scrapbooking
- Services for Home and Business
Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.
Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.
Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $3.8692, off by 7.20%, on 90,296 volume with 462 trades. The average volume for the last 60 days is 16,582 and the stock's 52-week low/high is $3.1674/$6.75.
- Youngevity Enters the $7.7B Cannabis Market with Hemp FX™ Product Line
- Youngevity International, Inc. (NASDAQ: YGYI) Revenues Perk Up with Coffee
- Youngevity Introduces New Products and Brands at 2018 Convention
NUGL Inc. (OTC: NUGL)
NUGL Inc. (OTC: NUGL), creator of the world’s first comprehensive cannabis software platform and a company setting a new technology standard for the cannabis industry, recently announced that it has hired renowned attorney Scott P. Shaw to serve as an expert industry consultant in IP and trademark law (http://nnw.fm/84K5b).
NUGL Inc. (OTC: NUGL) is focused on leading the evolution in business relations, development and organic data in the cannabis industry with a distinct platform. In this effort, it has developed a leading-edge, first of its kind search app and online directory for the marijuana industry that provides a one-stop source and listings for dispensaries, strains, doctors, lawyers, service professionals, vape shops, hydro stores and brands.
Headquartered in Chino Hills, California, which is home to a projected $5 billion legal marijuana marketplace, NUGL is on track to become a major asset for the global cannabis industry and related services sectors. The company recently established a strategic partnership with Thinklogic and appointed CEO Chris Adams to NUGL’s growing board of directors. Thinklogic is a top-level software development company specializing in projects for start-ups to Fortune 500 companies.
“This strategic partnership puts NUGL in a distinguished class, adding a first-rate technical software expert like Chris gives NUGL a unique technological advantage,” said Brandon Vargas CEO of NUGL. “With the addition of Chris’s knowledge and expertise combined with Thinklogics’ experienced and skilled staff, NUGL will have the ability to evolve and build a strong infrastructure unmatched in the 420 industry.”
NUGL is nearing completion of its initial launch timeline, with plans to launch the app on both Android and iOS platforms within the next few weeks. NUGL’s live testing of its software includes enhanced reviews that detail up to 10 category ratings. Each of the category rankings allow users to leave comments and choose among a 5-star rating among all categories or as few as they wish. The software’s rating platform allows for customization and transparency for users while providing invaluable feedback to shops and professional services.
“This is a major feature that is critical to our community,” said Jeff Odle, NUGL’s CTO. “Enhanced ratings will be a definitive difference validating our organic listings and raising the standard for the industry. We want the users to know what they are getting before they step into a store or sign up for a service.”
NUGL is growing its team of developers and launching new features on an ongoing basis. The company is ahead of an impressive timeline, which includes building blocks for scalability and massive growth.
“Everything we do is focused on user experience. Our philosophy is simple – make it fun and easy to use, with the purest and most unbiased results,” said Ryan Bartlette, NUGL CMO. “As the industry evolves and becomes more sophisticated, NUGL will adapt and build the best marketing technology for the cannabis-related companies. We have gotten in on the ground level and know the pulse of the industry.”
NUGL CEO Brandon Vargas is a founding member of G6 Management, a full-service consulting firm advising cannabis professionals in all aspects of business. With over 10 years’ experience in the cannabis space, he has worked on dispensary, cultivation and infusion entity formation, licensing, real estate acquisitions, construction and build out, marketing, policy and procedures, compliance, staffing, and capital raises. Vargas has an extensive background working with various medical marijuana companies on investment and in developing greenhouse and commercial cultivation, distillate for vapes cartridges, CBD oils and infusions.
CMO Ryan Bartlette is co-founder and CMO of 23Forty LLC and Boxy. He has expertly positioned and branded many companies while bringing them to market and is a sought out graphic artist, front-end developer, photographer, and visual artist with experience in the entertainment and technology industry.
Jeff Odle, NUGL CTO, is a successful senior software architect has a long and distinguished career developing some of the most innovative, cutting-edge platforms available. His unique and distinctive approach to creating the blueprint for advanced programming is industry leading and unprecedented. He is a top-level architect responsible for developing some of the most forward-looking software for various industries.
NUGL’s board of directors includes John R. Armstrong, a founding partner of Horwitz + Armstrong, a full service general business firm handling all aspects of litigation and business strategy and advice. Armstrong and his partner, Lawrence Hortwitz, have more than 10 years of experience in the cannabis space, representing cannabis professionals in all aspects of business including business formation, licensing, compliance with local and state regulations, real estate acquisitions, corporate mergers and acquisitions, financing, inclusive of capital raises and alternative financing, contracts, and all forms of dispute resolution.
Board member Hendrik Klein, founder of Da Vinci Asset Management, a privately-owned investment firm, serves as CEO and executive board member of Fritz Nols AG, a capital marketing consulting firm specializing in trading and asset management. Klein has received several industry awards including the Austrian Hedge Fund Award, the German Hedge Fund Award, and most recently was named the Global Best Performing Systematic Quantitative CTA. Klein and the Da Vinci team employ the latest quantitative data research and analysis in their innovative investment strategy.
NUGL Inc. (NUGL), closed the day's trading session at $1.39, off by 2.11%, on 81,808 volume with 115 trades. The average volume for the last 60 days is 121,396 and the stock's 52-week low/high is $0.405/$1.80.
- NUGL Inc. (NUGL) Engages ‘Super Lawyer’ as Consultant to Help Protect Growing Brand and Intellectual Property
- NUGL Inc. (NUGL) Aims to Set New Cannabis Industry Tech Standard with Innovative Networking App and Online Directory
- NUGL Brings on Super Lawyer as IP and Trademark Consultant
VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: VVCIF)
VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: VVCIF) this morning announced the release of its financial statements for the second quarter of 2018. To view the full press release, visit: http://nnw.fm/Ilw2N.
VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.
“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.
VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.
VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.
This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.
VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.
VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.
Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.
With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.
VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $1.3017, off by 2.86%, on 1,342,569 volume with 848 trades. The average volume for the last 60 days is 61,198 and the stock's 52-week low/high is $1.04/$1.3427.
- NetworkNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: VVCIF) Announces Release of Q2 2018 Fiscal Results
- CannabisNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: ABCCF) Enters Cannabis Supply Agreement with Ontario Cannabis Store
- VIVO Cannabis Selected as a Supplier to Ontario Retail Cannabis Market
Accelerated Technologies Holding Corp. (OTC: ATHC)
Accelerated Technologies Holding Corp. (OTC: ATHC) is a full-service end-to-end business solution and technology company that specializes in cloud-based disruptive technologies. The Company provides consulting and enterprise-level technology services and is developing its own disruptive technology products in the sectors of artificial social realities, short-term alternative funding platforms, electronic payment solutions, and blockchain technologies focused on social engagement, sports, entertainment and content creation.
ATHC is more than a publicly traded company determined to make a buck. Its mission is to create a pioneering business model by taking a leadership position in institutionalizing investment in the regional venture capital market. ATHC’s core values, beliefs and fundamentals revolve around today’s great visionaries – the great leaders of tomorrow. For young entrepreneurs, ATHC offers funding assistance, guidance and investment capital in return for reasonable equity, commitment and an unparalleled work ethic. ATHC and its economies of scale enable the Company to develop technology at reasonable costs while leveraging expertise and contacts for effective execution. The Company intends to create shareholder value by monetizing equity retained by ATHC.
ATHC’s investment domain and expertise lies in consumer Internet, cloud computing and software-as-a-service (Saas), mobile software and services, software-powered consumer electronics, infrastructure and applications software, networking, storage, databases and other backend systems. ATHC’s portfolio to date includes:
- Intelagy – a wholly owned subsidiary of Accelerated Technologies Holding Group, is all about bringing business to businesses. Intelagy provides services that every business’ needs in today’s dynamic and digital marketplace. These services include discounted Merchant Services, Merchant Cash Advances (working capital and loans for businesses), Mobile Processing, Web Design and Hosting solutions, Printing, Local Marketing, Online Marketing, Reputation Management, Prepaid Debit Card Solutions, Payroll Services, and Telecom needs for small, mid-sized and enterprise-level businesses.
- Finbridge Holdings provides capital to alternative lenders with receivables between $2 million and $5 million and to those operating in merchant cash advance and other short-term micro loan environments. Finbridge Holdings’ lending model provides ISOs with an alternative to private placement capital to obtain cash to grow their business. Finbridge intends to be a leader in the loans-to-lender space, primarily focused on those specializing in the small to medium business lending channel.
- XStreamCorp – a Reality Gaming Social Network. XStreamCorp presents an opportunity to penetrate popular social gaming networks by incorporating proprietary technologies that provide users with streaming video, audio and messaging capabilities. These enhancements will dramatically change the player experience in online gaming. Revenue is expected via sales of in-game virtual goods in Social Poker Play formats and events; in-game advertising; and banner advertising around the Company’s gaming portal.
- IconXchange will endeavor to provide a decentralized, open, resilient infrastructure for a new generation of human funding that includes blockchain-based IconXchange Coins and value-based IXC tokens. IconXchange aims to be a platform through which valuable brands are identified, grown, and incentivized. A value-based token enables enhanced liquidity and accelerated funding. IconXchange intends to capitalize on the blockchain’s evolution and improvement without being locked into any one protocol or platform.
ATHC is the destination to discover professionals, guidance, cross marketing opportunities, industry trends, and investments. The Company was built with a unique and scalable approach to collect, leverage and contribute to a strong community of venture capital partners, dynamic sales and marketing verticals, and in-house data teams armed with powerful machine learning, data science, development, management and execution skills. ATHC provides corporate consulting for private and publicly traded companies; technology planning and engineering services; installation and maintenance of cybersecurity resources; and venture capital and financing.
The management team at ATHC is driven, committed, and experienced in building infrastructure for startups. President Kevin H. Kading is the founder, chairman and CEO of Kading Companies S.A. Between 1979 and 1995, he held various positions at Wall Street investment banking firms. Since 1995, he has been a member of Securities Traders Association both nationally and in New York. Kading was a founder, officer, and chairman of the Board of Advanced Reconnaissance Corp. from 1997 to February 2006.
Managing director Alex M. Lemberg has worked as a business analyst on Wall Street since 1992 with the following companies: Merrill Lynch, Morgan Stanley, Barclays Capital, CIBC, Bank of America Securities, and Credit Suisse. He brings a vast understanding of the business process and the use of technologies in order to maintain a streamlined, user-friendly environment.
Accelerated Technologies Holding Corp. (ATHC), closed the day's trading session at $0.41, off by 17.67%, on 2,500 volume with 1 trade. The average volume for the last 60 days is 2,069 and the stock's 52-week low/high is $0.026/$1.00.
- Accelerated Technologies Holding Corp. (ATHC) Reports High Market Enthusiasm for Intelagy Service
- NetworkNewsBreaks – Accelerated Technologies Holding Corp. (ATHC) Subsidiary Targets the Budding Alternative Finance Market
- Accelerated Technologies Holding Corp. (ATHC) Investing in Digital Economy Future with Venture Capital Services Model
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Accelerated Technologies Holding Corp. (OTC: ATHC) Reports High Market Enthusiasm for Intelagy Service
- Aftermaster, Inc. (OTCQB: AFTM) to Host Shareholder Update Call on August 21, 2018
- American Helium (TSX.V: AHE) (OTC: AHELF) Provides Shareholder Update
- Auscrete Corp. (OTC: ASCK) Eyes Year-End Production Launch, Future International Growth in Canada and Cuba
- BLOCKStrain Technology Corp. (TSXV: DNAX) Protects, Enhances Visibility in Cannabis Supply Chain
- Cannabis Strategic Ventures, Inc. (OTC: NUGS) Cancels 75.6 Million Shares, Including 20 Million Shares From CEO
- Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Secures 12 Additional Cannabis Retail Opportunities in Alberta and British Columbia
- ChineseInvestors.com (OTCQB: CIIX) Launches Innovative CBD Direct Selling Initiative through Wholly Owned Foreign Enterprise
- Consorteum Holdings, Inc. (OTC: CSRH) Subsidiary Foresees an Auspicious Future for its UMI Platform
- CytoDyn Inc. (CYDY) Signs Definitive Agreement to Acquire ProstaGene; Founder and CEO Dr. Richard Pestell to Join CytoDyn as Interim Chief Medical Officer
- DeepMarkit Inc. (TSX.V: MKT) (OTCQB: MKTDF) Continues to Expand Customer Base
- DPW Holdings, Inc. (NYSE American: DPW) CEO to Present at the Rodman and Renshaw Global Investment Conference
- Earth Science Tech, Inc. (OTC: ETST) Initiates Up-Listing Process, Increasing Investor Exposure and Value
- FANDOM SPORTS Media (CSE:FDM) (OTC:FDMSF) (FRANKFURT:TQ42) Announces FANbassador Program
- FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Appoints Robert Kamm to its Board of Directors
- First Cobalt Corp. (TSX.V:FCC) (OTCQX:FTSSF) Interview Highlights ‘Agri-Blockchain’ Solution, Export/E-Commerce Relationships in Brazil and China
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Secures Additional Sale of QuadSight™ Prototype
- Global Payout, Inc. (OTC: GOHE) Provides Update on Marijuana Company of America Inc. (OTC: MCOA) Investment in Moneytrac Technology
- Green Hygienics Holdings Inc. (OTC Pink: GRYN) Appoints New Management to Lead Key Business Strategies
- GreenBox POS, LLC (OTC: GRBX) Responds to Notice from OTCMarkets
- GTX Corp (OTC: GTXO) Signs Distribution and Collaboration Agreement with KGH, Inc. and Adds Kathleen Kiernan to Advisor Board
- Hammer Fiber Optic Holdings Corp. (OTCQB: HMMR) FMW Media Works Corp.’s “Exploring The Block” and “NEW TO THE STREET” TV Shows Expand Global Viewership Into Asia with Media and Clients
- Hiku Brands Co. Ltd. (CSE: HIKU) (OTC: DJACF) New Merger Agreement with Canopy Growth and Potential Synergies
- Koios Beverage Corp. (CSE: KBEV) (OTC: SNOVF) Partners with Rocky Mountain Soda on New Production Line
- Lexaria Bioscience Corp. (CSE: LXX)(OTCQB: LXRP) Announces Positive Blood-Brain-Barrier Results
- Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) Continues Progressing in the Rapidly Growing Lithium Market
- Marifil Mines Ltd.’s (TSX.V: MFM) (OTCQB: MFMLF) Exploring Cobalt and Lithium Resources for Expanding Electric Vehicle Market
- Marijuana Company of America Inc. (OTC: MCOA) Provides Update on CBD Hemp Joint Venture Farming Project in New Brunswick Canada
- Medical Cannabis Payment Solutions (OTC: REFG) Payment Processing Continues to Present Challenge as Legalization of Cannabis Gains Momentum
- Net Element, Inc. (NASDAQ: NETE) Revenues Up Nine Percent to $32 Million
- NUGL Inc. (OTC: NUGL) Engages ‘Super Lawyer’ as Consultant to Help Protect Growing Brand and Intellectual Property
- Pacific Software, Inc. (OTC: PFSF) Interview Highlights ‘Agri-Blockchain’ Solution, Export/E-Commerce Relationships in Brazil and China
- Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Hires Former Apple Designer Brian Schmitt to Lead Visual Identity for new Oki Brand
- Petroteq Energy Inc. (TSX.V:PQE) (OTC:PQEFF) Sees Great Market Potential for Heavy Oil Product
- Pressure BioSciences Inc. (OTCQB: PBIO) Issued Key U.S. Patent for High-Pressure Flow-Through Microfluidic Sample Preparation Device
- PreveCeutical Medical Inc. (CSE:PREV) (OTCQB:PRVCF) (FSE:18H) Efforts to Establish Nature-Based Health and Wellness Products
- QMC Quantum Minerals Corp. (TSX-V: QMC) (FSE: 3LQ) (OTC: QMCQF) is Fired Up about No-Fire Lithium Batteries
- Sharing Services, Inc. (OTC: SHRV) Specialists in the Direct Selling Industry
- SinglePoint, Inc. (OTCQB: SING) Video: SinglePoint CEO Provides Update and Insight to Becoming Fully Reporting
- Sugarmade, Inc. (SGMD) Details Proposed Acquisitions in Hydroponic Supply Sector
- Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF) Stands Out Among Potential Leading Compliant Producers in California Cannabis Market
- The Flowr Corporation Chairman and Chief Strategist Discusses Company Activities, Outlook in Interview on The Brave New Weed Podcast
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Discusses its Organic Cannabis Strategy in Exclusive NetworkNewsWire Audio Interview
- TMSR Holding Company Ltd. (NASDAQ: TMSR) working with NetworkNewsWire
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQB: VVCIF) Announces Release of Q2 2018 Fiscal Results
- Virtual Crypto Technologies Inc. (OTCQB: VRCP) CryptoNewsAudio Announces Audio Press Release (APR) on Virtual Crypto Technologies Inc. Bridging the Crypto Gap with NetoBit ATMs
- Youngevity International, Inc. (NASDAQ: YGYI) Enters the $7.7B Cannabis Market with Hemp FX™ Product Line
- WhereverTV Broadcasting Corp. (TVTV) Signs SiriusXM’s “The Highway” Morning Show Host Storme Warren
- Zenergy Brands, Inc. (OTC: ZNGY) Zero Cost Program Makes Energy Conservation More Accessible
- Zenosense, Inc. (OTCQB: ZENO) MIDS Cardiac™ Uniquely Designed to Provide Lab-Comparable Accuracy in Minutes at Point of Care
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.